Gene-Sequencing Company Illumina to Sell Cancer Test Developer

The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.

Related Keywords

Lina Khan ,Jacob Thaysen , ,Genetic Engineering ,Medical Test ,Competition Law ,Decisions And Verdicts ,Mergers And Acquisitions ,Regulation And Deregulation ,Eu ,Ftc ,Grail ,Illumina ,